This review systematically examines the mechanisms of osteopontin (OPN) in various liver diseases—including acute liver injury, alcoholic liver disease, viral hepatitis, metabolic-associated fatty liver disease, and hepatocellular carcinoma—with a particular focus on its cell-type-specific functional roles and associated signaling networks. This evidence concerns the gene SPP1 and liver disorder.